A regional healthcare system is integrating a novel quantitative cerebrospinal fluid biomarker assay for viral encephalitis. The diagnostic committee is reviewing how different implementation strategies and threshold adjustments will impact the assay's statistical performance. Match each proposed clinical or laboratory modification with its most accurate statistical consequence.
- Decreasing the quantitative threshold required to report a 'positive' biomarker resultIncreases the assay's sensitivity and negative predictive value, while decreasing its specificity.
- Restricting the assay's use to patients with meningeal signs and known risk factors, rather than testing all patients with a headacheIncreases the positive predictive value and decreases the negative predictive value, while the likelihood ratios remain unchanged.
- Increasing the required quantitative threshold to report a 'positive' biomarker resultIncreases the assay's specificity and positive predictive value, while decreasing its sensitivity.
- Expanding the assay's use as a universal screening tool for all asymptomatic clinic visitors in the regionIncreases the negative predictive value and decreases the positive predictive value, while the likelihood ratios remain unchanged.
Cevap
The correct matches reflect the fundamental rules of diagnostic testing: altering the test cutoff changes its inherent sensitivity and specificity, while changing the tested population's risk level alters ONLY the predictive values without affecting inherent test characteristics.
The correct pairings accurately reflect how changes in test design (cutoffs) alter sensitivity and specificity, whereas changes in clinical application (prevalence) alter predictive values without changing the test's inherent likelihood ratios.
Adım Adım Çözüm
Anahtar Kavram
Diagnostic Testing Performance: Cutoff thresholds vs. Disease Prevalence